Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | serine/threonine protein kinase | 0.0129 | 0.6658 | 0.6658 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0047 | 0.0958 | 1 |
Echinococcus multilocularis | RNA directed DNA polymerase | 0.0115 | 0.5671 | 0.5671 |
Echinococcus granulosus | RNA directed DNA polymerase | 0.0115 | 0.5671 | 0.5671 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0047 | 0.0958 | 0.5 |
Schistosoma mansoni | atypical protein kinase C | 0.0057 | 0.1639 | 0.1639 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0047 | 0.0958 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0047 | 0.0958 | 0.1311 |
Echinococcus multilocularis | protein kinase c iota type | 0.0057 | 0.1639 | 0.1639 |
Loa Loa (eye worm) | hypothetical protein | 0.0138 | 0.731 | 1 |
Brugia malayi | intracellular kinase | 0.0047 | 0.0958 | 0.1239 |
Giardia lamblia | Kinase, CMGC GSK | 0.0047 | 0.0958 | 0.5 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0129 | 0.6658 | 0.9108 |
Echinococcus multilocularis | protein kinase shaggy | 0.0047 | 0.0958 | 0.0958 |
Echinococcus multilocularis | telomerase reverse transcriptase subunit | 0.0115 | 0.5671 | 0.5671 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0177 | 1 | 1 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0129 | 0.6658 | 0.6658 |
Brugia malayi | Protein kinase c protein 2 | 0.0144 | 0.7732 | 1 |
Echinococcus granulosus | protein kinase C gamma type | 0.0153 | 0.8361 | 0.8361 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0047 | 0.0958 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0047 | 0.0958 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0047 | 0.0958 | 0.3976 |
Echinococcus granulosus | protein kinase c iota type | 0.0057 | 0.1639 | 0.1639 |
Entamoeba histolytica | protein kinase, putative | 0.0047 | 0.0958 | 0.3976 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.0121 | 0.6092 | 0.8335 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0047 | 0.0958 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.5671 | 0.7758 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0047 | 0.0958 | 0.3976 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0177 | 1 | 1 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.0068 | 0.241 | 0.241 |
Echinococcus granulosus | protein kinase shaggy | 0.0047 | 0.0958 | 0.0958 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0177 | 1 | 1 |
Brugia malayi | protein kinase C II. | 0.0129 | 0.6658 | 0.8612 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0101 | 0.4679 | 0.4679 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0047 | 0.0958 | 0.0958 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0153 | 0.8361 | 0.8361 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0047 | 0.0958 | 0.5 |
Giardia lamblia | Kinase, CMGC GSK | 0.0047 | 0.0958 | 0.5 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0129 | 0.6658 | 0.6658 |
Trypanosoma brucei | protein kinase, putative | 0.0047 | 0.0958 | 1 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0047 | 0.0958 | 0.0958 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0047 | 0.0958 | 0.0958 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0047 | 0.0958 | 0.1311 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0068 | 0.241 | 1 |
Onchocerca volvulus | 0.0047 | 0.0958 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.